You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloid Malignancies

Showing 1 - 25 of 5,414
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloid Malignancies Trial in Chendu (fractionated busulfan-based conditioning regimen)

Recruiting
  • Myeloid Malignancies
  • fractionated busulfan-based conditioning regimen
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Mar 29, 2023

Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

Not yet recruiting
  • Myeloid Malignancies
  • +3 more
  • (no location specified)
Mar 22, 2023

Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)

Recruiting
  • Hypomethylating Agent
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Cyclophosphamide, Mesna, Filgrastim)

    Recruiting
    • Myeloid Malignancies
    • +3 more
    • Houston, Texas
      M D Anderson Caner Center
    Nov 17, 2022

    Acute Myeloid Leukemia, MDS, Myeloid Malignancies Trial in Boston (Decitabine, Filgrastim)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Mar 31, 2023

    Leukemia, Myeloid, Acute, MDS, Hematopoietic Stem Cell Transplantation Trial in Shanghai (Venetoclax plus RIC)

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • +3 more
    • Venetoclax plus RIC
    • Shanghai, Shanghai, China
      Shanghai General Hospital
    Oct 12, 2022

    Leukemia Trial (Donor Enriched Activated Natural Killer Cell Infusion)

    Withdrawn
    • Leukemia
    • Donor Enriched Activated Natural Killer Cell Infusion
    • (no location specified)
    Dec 20, 2022

    Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy

    Recruiting
    • Myelodysplastic Syndromes
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 31, 2023

      Myeloid Malignancy, Acute Myeloid Leukemia, MDS Trial in Rochester (Telehealth Serious Illness Care Program, Education Control)

      Not yet recruiting
      • Myeloid Malignancy
      • +4 more
      • Telehealth Serious Illness Care Program
      • Education Control
      • Rochester, New York
        University of Rochester
      May 24, 2023

      MDS, MDS/MPN Crossover Syndromes Trial in Cleveland (5-azacytidine, Decitabine)

      Recruiting
      • Myelodysplastic Syndromes
      • MDS/MPN Crossover Syndromes
      • Cleveland, Ohio
        Cleveland Medical Center, University Hospitals Seidman Cancer Ce
      Aug 10, 2022

      Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial

      Completed
      • Aggressive Systemic Mastocytosis
      • +3 more
      • Stanford, California
      • +10 more
      Jan 12, 2023

      Disease-free Survival Trial in Shanghai (MBF-RIC)

      Recruiting
      • Disease-free Survival
      • Shanghai, Shanghai, China
      • +1 more
      Jun 28, 2022

      Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, MDS Trial in Saint Petersburg (Bendamustine Hydrochloride, Cyclophosphamid)

      Recruiting
      • Myeloid Leukemia, Acute
      • +3 more
      • Saint Petersburg, Russian Federation
        RM Gorbacheva Research Institute
      Apr 4, 2022

      Leukemia, Myeloid, Acute Trial (GSK3745417)

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • (no location specified)
      Jun 15, 2022

      Allogenic Stem Cell Transplantation Trial (SAR445419)

      Not yet recruiting
      • Allogenic Stem Cell Transplantation
      • (no location specified)
      Feb 13, 2023

      Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

      Active, not recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • Fludarabine, busulfan and melphalan
      • Fludarabine and Busulfan
      • Fuzhou, Fujian, China
      • +8 more
      Aug 14, 2023

      Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

      Recruiting
      • Myeloid Malignancy
      • +4 more
      • Boston, Massachusetts
      • +2 more
      Jul 21, 2022

      Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Adelaide (IMG-7289, All-trans retinoic acid)

      Completed
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndrome
      • Adelaide, South Australia, Australia
        Royal Adelaide Hospital
      Jan 24, 2022

      Intravenous Busulfan And Fludarabine Myeloablative Conditioning

      Completed
      • Acute Myeloid Leukemia
      • +3 more
        • (no location specified)
        Mar 16, 2022

        Relapsed/Refractory AML, Minimal Residual Disease Positive AML, Myelodysplastic Syndrome Trial in Worldwide (AMG 330)

        Terminated
        • Relapsed/Refractory AML
        • +2 more
        • AMG 330
        • Birmingham, Alabama
        • +10 more
        Nov 9, 2022

        Acute Myeloid Leukemia, Relapsed Cancer, Refractory Cancer Trial in Edmonton, Toronto (Enasidenib, Venetoclax)

        Active, not recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • Edmonton, Alberta, Canada
        • +1 more
        Jan 31, 2023

        Myeloid Malignancies Trial in Italy (GvHD prophylaxis)

        Recruiting
        • Myeloid Malignancies
        • GvHD prophylaxis
        • Alessandria, Italy
        • +32 more
        Nov 23, 2022

        Myeloid Malignancies Trial in Australia, United Kingdom, United States (Magrolimab, Azacitidine, Venetoclax)

        Recruiting
        • Myeloid Malignancies
        • Magrolimab
        • +6 more
        • Birmingham, Alabama
        • +12 more
        Apr 6, 2022

        Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the

        Not yet recruiting
        • Inherited Bone Marrow Failure Syndrome
        • Familial Platelet Disorder With Predisposition to Myeloid Malignancies
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Oct 20, 2023